Global Predictive and Presymptomatic Testing Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Predictive genetic testing searches for genetic changes, or mutations, that are linked to disease. These tests are done before you show any signs of a disease.
The global market for Predictive and Presymptomatic Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Predictive and Presymptomatic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Predictive and Presymptomatic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Predictive and Presymptomatic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Predictive and Presymptomatic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Predictive and Presymptomatic Testing players cover 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc. and Direct Laboratory Services LLC (DirectLabs), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Predictive and Presymptomatic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Predictive and Presymptomatic Testing market, with both quantitative and qualitative data, to help readers understand how the Predictive and Presymptomatic Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Predictive and Presymptomatic Testing market and forecasts the market size by Type (Presymptomatic Testing and Predispositional Testing,), by Application (Breast and Ovarian Cancer, Colorectal Cancer, Alzheimer's Disease and Multiple Endocrine Neoplasia Type 2), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Predictive and Presymptomatic Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Predictive and Presymptomatic Testing market size and CAGR, Predictive and Presymptomatic Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Predictive and Presymptomatic Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Predictive and Presymptomatic Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Predictive and Presymptomatic Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc., Direct Laboratory Services LLC (DirectLabs), Gene by Gene Ltd., Genomic Diagnostics, Mapmygenome and Myriad Genetics, Inc., etc.
Chapter 14: Research Findings and Conclusion
Predictive genetic testing searches for genetic changes, or mutations, that are linked to disease. These tests are done before you show any signs of a disease.
The global market for Predictive and Presymptomatic Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Predictive and Presymptomatic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Predictive and Presymptomatic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Predictive and Presymptomatic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Predictive and Presymptomatic Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Predictive and Presymptomatic Testing players cover 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc. and Direct Laboratory Services LLC (DirectLabs), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Predictive and Presymptomatic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Predictive and Presymptomatic Testing market, with both quantitative and qualitative data, to help readers understand how the Predictive and Presymptomatic Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Predictive and Presymptomatic Testing market and forecasts the market size by Type (Presymptomatic Testing and Predispositional Testing,), by Application (Breast and Ovarian Cancer, Colorectal Cancer, Alzheimer's Disease and Multiple Endocrine Neoplasia Type 2), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Presymptomatic Testing
- Predispositional Testing
- Breast and Ovarian Cancer
- Colorectal Cancer
- Alzheimer's Disease
- Multiple Endocrine Neoplasia Type 2
- Haemochromatosis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- 23andMe, Inc.
- Abbott Molecular, Inc.
- BioAxis DNA Research Centre Private Limited
- Color Genomics, Inc.
- Direct Laboratory Services LLC (DirectLabs)
- Gene by Gene Ltd.
- Genomic Diagnostics
- Mapmygenome
- Myriad Genetics, Inc.
- Pathway Genomics Corporation
- Positive Bioscience, Inc.
- Quest Diagnostics, Inc.
Chapter 1: Scope of Predictive and Presymptomatic Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Predictive and Presymptomatic Testing market size and CAGR, Predictive and Presymptomatic Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Predictive and Presymptomatic Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Predictive and Presymptomatic Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Predictive and Presymptomatic Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc., Direct Laboratory Services LLC (DirectLabs), Gene by Gene Ltd., Genomic Diagnostics, Mapmygenome and Myriad Genetics, Inc., etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Predictive and Presymptomatic Testing Market Size 2017-2028
2.1.2 Predictive and Presymptomatic Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Predictive and Presymptomatic Testing Segment by Type
2.2.1 Presymptomatic Testing
2.2.2 Predispositional Testing
2.3 Predictive and Presymptomatic Testing Market Size by Type
2.3.1 Predictive and Presymptomatic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
2.4 Predictive and Presymptomatic Testing Segment by Application
2.4.1 Breast and Ovarian Cancer
2.4.2 Colorectal Cancer
2.4.3 Alzheimer's Disease
2.4.4 Multiple Endocrine Neoplasia Type
2.4.5 Haemochromatosis
2.5 Predictive and Presymptomatic Testing Market Size by Application
2.5.1 Predictive and Presymptomatic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
3 PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET SIZE BY PLAYER
3.1 Predictive and Presymptomatic Testing Market Size Market Share by Players
3.1.1 Global Predictive and Presymptomatic Testing Revenue by Players (2020-2022)
3.1.2 Global Predictive and Presymptomatic Testing Revenue Market Share by Players (2020-2022)
3.2 Global Predictive and Presymptomatic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PREDICTIVE AND PRESYMPTOMATIC TESTING BY REGIONS
4.1 Predictive and Presymptomatic Testing Market Size by Regions (2017-2022)
4.2 Americas Predictive and Presymptomatic Testing Market Size Growth (2017-2022)
4.3 APAC Predictive and Presymptomatic Testing Market Size Growth (2017-2022)
4.4 Europe Predictive and Presymptomatic Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa Predictive and Presymptomatic Testing Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Predictive and Presymptomatic Testing Market Size by Country (2017-2022)
5.2 Americas Predictive and Presymptomatic Testing Market Size by Type (2017-2022)
5.3 Americas Predictive and Presymptomatic Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Predictive and Presymptomatic Testing Market Size by Region (2017-2022)
6.2 APAC Predictive and Presymptomatic Testing Market Size by Type (2017-2022)
6.3 APAC Predictive and Presymptomatic Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Predictive and Presymptomatic Testing by Country (2017-2022)
7.2 Europe Predictive and Presymptomatic Testing Market Size by Type (2017-2022)
7.3 Europe Predictive and Presymptomatic Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Predictive and Presymptomatic Testing by Region (2017-2022)
8.2 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET FORECAST
10.1 Global Predictive and Presymptomatic Testing Forecast by Regions (2023-2028)
10.1.1 Global Predictive and Presymptomatic Testing Forecast by Regions (2023-2028)
10.1.2 Americas Predictive and Presymptomatic Testing Forecast
10.1.3 APAC Predictive and Presymptomatic Testing Forecast
10.1.4 Europe Predictive and Presymptomatic Testing Forecast
10.1.5 Middle East & Africa Predictive and Presymptomatic Testing Forecast
10.2 Americas Predictive and Presymptomatic Testing Forecast by Country (2023-2028)
10.2.1 United States Predictive and Presymptomatic Testing Market Forecast
10.2.2 Canada Predictive and Presymptomatic Testing Market Forecast
10.2.3 Mexico Predictive and Presymptomatic Testing Market Forecast
10.2.4 Brazil Predictive and Presymptomatic Testing Market Forecast
10.3 APAC Predictive and Presymptomatic Testing Forecast by Region (2023-2028)
10.3.1 China Predictive and Presymptomatic Testing Market Forecast
10.3.2 Japan Predictive and Presymptomatic Testing Market Forecast
10.3.3 Korea Predictive and Presymptomatic Testing Market Forecast
10.3.4 Southeast Asia Predictive and Presymptomatic Testing Market Forecast
10.3.5 India Predictive and Presymptomatic Testing Market Forecast
10.3.6 Australia Predictive and Presymptomatic Testing Market Forecast
10.4 Europe Predictive and Presymptomatic Testing Forecast by Country (2023-2028)
10.4.1 Germany Predictive and Presymptomatic Testing Market Forecast
10.4.2 France Predictive and Presymptomatic Testing Market Forecast
10.4.3 UK Predictive and Presymptomatic Testing Market Forecast
10.4.4 Italy Predictive and Presymptomatic Testing Market Forecast
10.4.5 Russia Predictive and Presymptomatic Testing Market Forecast
10.5 Middle East & Africa Predictive and Presymptomatic Testing Forecast by Region (2023-2028)
10.5.1 Egypt Predictive and Presymptomatic Testing Market Forecast
10.5.2 South Africa Predictive and Presymptomatic Testing Market Forecast
10.5.3 Israel Predictive and Presymptomatic Testing Market Forecast
10.5.4 Turkey Predictive and Presymptomatic Testing Market Forecast
10.5.5 GCC Countries Predictive and Presymptomatic Testing Market Forecast
10.6 Global Predictive and Presymptomatic Testing Forecast by Type (2023-2028)
10.7 Global Predictive and Presymptomatic Testing Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 23andMe, Inc.
11.1.1 23andMe, Inc. Company Information
11.1.2 23andMe, Inc. Predictive and Presymptomatic Testing Product Offered
11.1.3 23andMe, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 23andMe, Inc. Main Business Overview
11.1.5 23andMe, Inc. Latest Developments
11.2 Abbott Molecular, Inc.
11.2.1 Abbott Molecular, Inc. Company Information
11.2.2 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product Offered
11.2.3 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbott Molecular, Inc. Main Business Overview
11.2.5 Abbott Molecular, Inc. Latest Developments
11.3 BioAxis DNA Research Centre Private Limited
11.3.1 BioAxis DNA Research Centre Private Limited Company Information
11.3.2 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product Offered
11.3.3 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 BioAxis DNA Research Centre Private Limited Main Business Overview
11.3.5 BioAxis DNA Research Centre Private Limited Latest Developments
11.4 Color Genomics, Inc.
11.4.1 Color Genomics, Inc. Company Information
11.4.2 Color Genomics, Inc. Predictive and Presymptomatic Testing Product Offered
11.4.3 Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Color Genomics, Inc. Main Business Overview
11.4.5 Color Genomics, Inc. Latest Developments
11.5 Direct Laboratory Services LLC (DirectLabs)
11.5.1 Direct Laboratory Services LLC (DirectLabs) Company Information
11.5.2 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product Offered
11.5.3 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Direct Laboratory Services LLC (DirectLabs) Main Business Overview
11.5.5 Direct Laboratory Services LLC (DirectLabs) Latest Developments
11.6 Gene by Gene Ltd.
11.6.1 Gene by Gene Ltd. Company Information
11.6.2 Gene by Gene Ltd. Predictive and Presymptomatic Testing Product Offered
11.6.3 Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Gene by Gene Ltd. Main Business Overview
11.6.5 Gene by Gene Ltd. Latest Developments
11.7 Genomic Diagnostics
11.7.1 Genomic Diagnostics Company Information
11.7.2 Genomic Diagnostics Predictive and Presymptomatic Testing Product Offered
11.7.3 Genomic Diagnostics Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Genomic Diagnostics Main Business Overview
11.7.5 Genomic Diagnostics Latest Developments
11.8 Mapmygenome
11.8.1 Mapmygenome Company Information
11.8.2 Mapmygenome Predictive and Presymptomatic Testing Product Offered
11.8.3 Mapmygenome Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Mapmygenome Main Business Overview
11.8.5 Mapmygenome Latest Developments
11.9 Myriad Genetics, Inc.
11.9.1 Myriad Genetics, Inc. Company Information
11.9.2 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product Offered
11.9.3 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Myriad Genetics, Inc. Main Business Overview
11.9.5 Myriad Genetics, Inc. Latest Developments
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Information
11.10.2 Pathway Genomics Corporation Predictive and Presymptomatic Testing Product Offered
11.10.3 Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Pathway Genomics Corporation Main Business Overview
11.10.5 Pathway Genomics Corporation Latest Developments
11.11 Positive Bioscience, Inc.
11.11.1 Positive Bioscience, Inc. Company Information
11.11.2 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product Offered
11.11.3 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Positive Bioscience, Inc. Main Business Overview
11.11.5 Positive Bioscience, Inc. Latest Developments
11.12 Quest Diagnostics, Inc.
11.12.1 Quest Diagnostics, Inc. Company Information
11.12.2 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product Offered
11.12.3 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Quest Diagnostics, Inc. Main Business Overview
11.12.5 Quest Diagnostics, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Predictive and Presymptomatic Testing Market Size 2017-2028
2.1.2 Predictive and Presymptomatic Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Predictive and Presymptomatic Testing Segment by Type
2.2.1 Presymptomatic Testing
2.2.2 Predispositional Testing
2.3 Predictive and Presymptomatic Testing Market Size by Type
2.3.1 Predictive and Presymptomatic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
2.4 Predictive and Presymptomatic Testing Segment by Application
2.4.1 Breast and Ovarian Cancer
2.4.2 Colorectal Cancer
2.4.3 Alzheimer's Disease
2.4.4 Multiple Endocrine Neoplasia Type
2.4.5 Haemochromatosis
2.5 Predictive and Presymptomatic Testing Market Size by Application
2.5.1 Predictive and Presymptomatic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
3 PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET SIZE BY PLAYER
3.1 Predictive and Presymptomatic Testing Market Size Market Share by Players
3.1.1 Global Predictive and Presymptomatic Testing Revenue by Players (2020-2022)
3.1.2 Global Predictive and Presymptomatic Testing Revenue Market Share by Players (2020-2022)
3.2 Global Predictive and Presymptomatic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PREDICTIVE AND PRESYMPTOMATIC TESTING BY REGIONS
4.1 Predictive and Presymptomatic Testing Market Size by Regions (2017-2022)
4.2 Americas Predictive and Presymptomatic Testing Market Size Growth (2017-2022)
4.3 APAC Predictive and Presymptomatic Testing Market Size Growth (2017-2022)
4.4 Europe Predictive and Presymptomatic Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa Predictive and Presymptomatic Testing Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Predictive and Presymptomatic Testing Market Size by Country (2017-2022)
5.2 Americas Predictive and Presymptomatic Testing Market Size by Type (2017-2022)
5.3 Americas Predictive and Presymptomatic Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Predictive and Presymptomatic Testing Market Size by Region (2017-2022)
6.2 APAC Predictive and Presymptomatic Testing Market Size by Type (2017-2022)
6.3 APAC Predictive and Presymptomatic Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Predictive and Presymptomatic Testing by Country (2017-2022)
7.2 Europe Predictive and Presymptomatic Testing Market Size by Type (2017-2022)
7.3 Europe Predictive and Presymptomatic Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Predictive and Presymptomatic Testing by Region (2017-2022)
8.2 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET FORECAST
10.1 Global Predictive and Presymptomatic Testing Forecast by Regions (2023-2028)
10.1.1 Global Predictive and Presymptomatic Testing Forecast by Regions (2023-2028)
10.1.2 Americas Predictive and Presymptomatic Testing Forecast
10.1.3 APAC Predictive and Presymptomatic Testing Forecast
10.1.4 Europe Predictive and Presymptomatic Testing Forecast
10.1.5 Middle East & Africa Predictive and Presymptomatic Testing Forecast
10.2 Americas Predictive and Presymptomatic Testing Forecast by Country (2023-2028)
10.2.1 United States Predictive and Presymptomatic Testing Market Forecast
10.2.2 Canada Predictive and Presymptomatic Testing Market Forecast
10.2.3 Mexico Predictive and Presymptomatic Testing Market Forecast
10.2.4 Brazil Predictive and Presymptomatic Testing Market Forecast
10.3 APAC Predictive and Presymptomatic Testing Forecast by Region (2023-2028)
10.3.1 China Predictive and Presymptomatic Testing Market Forecast
10.3.2 Japan Predictive and Presymptomatic Testing Market Forecast
10.3.3 Korea Predictive and Presymptomatic Testing Market Forecast
10.3.4 Southeast Asia Predictive and Presymptomatic Testing Market Forecast
10.3.5 India Predictive and Presymptomatic Testing Market Forecast
10.3.6 Australia Predictive and Presymptomatic Testing Market Forecast
10.4 Europe Predictive and Presymptomatic Testing Forecast by Country (2023-2028)
10.4.1 Germany Predictive and Presymptomatic Testing Market Forecast
10.4.2 France Predictive and Presymptomatic Testing Market Forecast
10.4.3 UK Predictive and Presymptomatic Testing Market Forecast
10.4.4 Italy Predictive and Presymptomatic Testing Market Forecast
10.4.5 Russia Predictive and Presymptomatic Testing Market Forecast
10.5 Middle East & Africa Predictive and Presymptomatic Testing Forecast by Region (2023-2028)
10.5.1 Egypt Predictive and Presymptomatic Testing Market Forecast
10.5.2 South Africa Predictive and Presymptomatic Testing Market Forecast
10.5.3 Israel Predictive and Presymptomatic Testing Market Forecast
10.5.4 Turkey Predictive and Presymptomatic Testing Market Forecast
10.5.5 GCC Countries Predictive and Presymptomatic Testing Market Forecast
10.6 Global Predictive and Presymptomatic Testing Forecast by Type (2023-2028)
10.7 Global Predictive and Presymptomatic Testing Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 23andMe, Inc.
11.1.1 23andMe, Inc. Company Information
11.1.2 23andMe, Inc. Predictive and Presymptomatic Testing Product Offered
11.1.3 23andMe, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 23andMe, Inc. Main Business Overview
11.1.5 23andMe, Inc. Latest Developments
11.2 Abbott Molecular, Inc.
11.2.1 Abbott Molecular, Inc. Company Information
11.2.2 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product Offered
11.2.3 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbott Molecular, Inc. Main Business Overview
11.2.5 Abbott Molecular, Inc. Latest Developments
11.3 BioAxis DNA Research Centre Private Limited
11.3.1 BioAxis DNA Research Centre Private Limited Company Information
11.3.2 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product Offered
11.3.3 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 BioAxis DNA Research Centre Private Limited Main Business Overview
11.3.5 BioAxis DNA Research Centre Private Limited Latest Developments
11.4 Color Genomics, Inc.
11.4.1 Color Genomics, Inc. Company Information
11.4.2 Color Genomics, Inc. Predictive and Presymptomatic Testing Product Offered
11.4.3 Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Color Genomics, Inc. Main Business Overview
11.4.5 Color Genomics, Inc. Latest Developments
11.5 Direct Laboratory Services LLC (DirectLabs)
11.5.1 Direct Laboratory Services LLC (DirectLabs) Company Information
11.5.2 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product Offered
11.5.3 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Direct Laboratory Services LLC (DirectLabs) Main Business Overview
11.5.5 Direct Laboratory Services LLC (DirectLabs) Latest Developments
11.6 Gene by Gene Ltd.
11.6.1 Gene by Gene Ltd. Company Information
11.6.2 Gene by Gene Ltd. Predictive and Presymptomatic Testing Product Offered
11.6.3 Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Gene by Gene Ltd. Main Business Overview
11.6.5 Gene by Gene Ltd. Latest Developments
11.7 Genomic Diagnostics
11.7.1 Genomic Diagnostics Company Information
11.7.2 Genomic Diagnostics Predictive and Presymptomatic Testing Product Offered
11.7.3 Genomic Diagnostics Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Genomic Diagnostics Main Business Overview
11.7.5 Genomic Diagnostics Latest Developments
11.8 Mapmygenome
11.8.1 Mapmygenome Company Information
11.8.2 Mapmygenome Predictive and Presymptomatic Testing Product Offered
11.8.3 Mapmygenome Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Mapmygenome Main Business Overview
11.8.5 Mapmygenome Latest Developments
11.9 Myriad Genetics, Inc.
11.9.1 Myriad Genetics, Inc. Company Information
11.9.2 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product Offered
11.9.3 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Myriad Genetics, Inc. Main Business Overview
11.9.5 Myriad Genetics, Inc. Latest Developments
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Information
11.10.2 Pathway Genomics Corporation Predictive and Presymptomatic Testing Product Offered
11.10.3 Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Pathway Genomics Corporation Main Business Overview
11.10.5 Pathway Genomics Corporation Latest Developments
11.11 Positive Bioscience, Inc.
11.11.1 Positive Bioscience, Inc. Company Information
11.11.2 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product Offered
11.11.3 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Positive Bioscience, Inc. Main Business Overview
11.11.5 Positive Bioscience, Inc. Latest Developments
11.12 Quest Diagnostics, Inc.
11.12.1 Quest Diagnostics, Inc. Company Information
11.12.2 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product Offered
11.12.3 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Quest Diagnostics, Inc. Main Business Overview
11.12.5 Quest Diagnostics, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Predictive and Presymptomatic Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Presymptomatic Testing
Table 3. Major Players of Predispositional Testing
Table 4. Predictive and Presymptomatic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Predictive and Presymptomatic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
Table 7. Predictive and Presymptomatic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Predictive and Presymptomatic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
Table 10. Global Predictive and Presymptomatic Testing Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Predictive and Presymptomatic Testing Revenue Market Share by Player (2020-2022)
Table 12. Predictive and Presymptomatic Testing Key Players Head office and Products Offered
Table 13. Predictive and Presymptomatic Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Predictive and Presymptomatic Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Predictive and Presymptomatic Testing Market Size Market Share by Regions (2017-2022)
Table 18. Americas Predictive and Presymptomatic Testing Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Predictive and Presymptomatic Testing Market Size Market Share by Country (2017-2022)
Table 20. Americas Predictive and Presymptomatic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
Table 22. Americas Predictive and Presymptomatic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
Table 24. APAC Predictive and Presymptomatic Testing Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Predictive and Presymptomatic Testing Market Size Market Share by Region (2017-2022)
Table 26. APAC Predictive and Presymptomatic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
Table 28. APAC Predictive and Presymptomatic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
Table 30. Europe Predictive and Presymptomatic Testing Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Predictive and Presymptomatic Testing Market Size Market Share by Country (2017-2022)
Table 32. Europe Predictive and Presymptomatic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
Table 34. Europe Predictive and Presymptomatic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Predictive and Presymptomatic Testing Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Predictive and Presymptomatic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Predictive and Presymptomatic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Predictive and Presymptomatic Testing
Table 43. Key Market Challenges & Risks of Predictive and Presymptomatic Testing
Table 44. Key Industry Trends of Predictive and Presymptomatic Testing
Table 45. Global Predictive and Presymptomatic Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Predictive and Presymptomatic Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Predictive and Presymptomatic Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Predictive and Presymptomatic Testing Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Predictive and Presymptomatic Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Predictive and Presymptomatic Testing Market Size Market Share Forecast by Application (2023-2028)
Table 51. 23andMe, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 52. 23andMe, Inc. Predictive and Presymptomatic Testing Product Offered
Table 53. 23andMe, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. 23andMe, Inc. Main Business
Table 55. 23andMe, Inc. Latest Developments
Table 56. Abbott Molecular, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 57. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product Offered
Table 58. Abbott Molecular, Inc. Main Business
Table 59. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Abbott Molecular, Inc. Latest Developments
Table 61. BioAxis DNA Research Centre Private Limited Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 62. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product Offered
Table 63. BioAxis DNA Research Centre Private Limited Main Business
Table 64. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. BioAxis DNA Research Centre Private Limited Latest Developments
Table 66. Color Genomics, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 67. Color Genomics, Inc. Predictive and Presymptomatic Testing Product Offered
Table 68. Color Genomics, Inc. Main Business
Table 69. Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Color Genomics, Inc. Latest Developments
Table 71. Direct Laboratory Services LLC (DirectLabs) Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 72. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product Offered
Table 73. Direct Laboratory Services LLC (DirectLabs) Main Business
Table 74. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Direct Laboratory Services LLC (DirectLabs) Latest Developments
Table 76. Gene by Gene Ltd. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 77. Gene by Gene Ltd. Predictive and Presymptomatic Testing Product Offered
Table 78. Gene by Gene Ltd. Main Business
Table 79. Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Gene by Gene Ltd. Latest Developments
Table 81. Genomic Diagnostics Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 82. Genomic Diagnostics Predictive and Presymptomatic Testing Product Offered
Table 83. Genomic Diagnostics Main Business
Table 84. Genomic Diagnostics Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Genomic Diagnostics Latest Developments
Table 86. Mapmygenome Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 87. Mapmygenome Predictive and Presymptomatic Testing Product Offered
Table 88. Mapmygenome Main Business
Table 89. Mapmygenome Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Mapmygenome Latest Developments
Table 91. Myriad Genetics, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 92. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product Offered
Table 93. Myriad Genetics, Inc. Main Business
Table 94. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Myriad Genetics, Inc. Latest Developments
Table 96. Pathway Genomics Corporation Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 97. Pathway Genomics Corporation Predictive and Presymptomatic Testing Product Offered
Table 98. Pathway Genomics Corporation Main Business
Table 99. Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Pathway Genomics Corporation Latest Developments
Table 101. Positive Bioscience, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 102. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product Offered
Table 103. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Positive Bioscience, Inc. Main Business
Table 105. Positive Bioscience, Inc. Latest Developments
Table 106. Quest Diagnostics, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 107. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product Offered
Table 108. Quest Diagnostics, Inc. Main Business
Table 109. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Quest Diagnostics, Inc. Latest Developments
Table 1. Predictive and Presymptomatic Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Presymptomatic Testing
Table 3. Major Players of Predispositional Testing
Table 4. Predictive and Presymptomatic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Predictive and Presymptomatic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
Table 7. Predictive and Presymptomatic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Predictive and Presymptomatic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
Table 10. Global Predictive and Presymptomatic Testing Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Predictive and Presymptomatic Testing Revenue Market Share by Player (2020-2022)
Table 12. Predictive and Presymptomatic Testing Key Players Head office and Products Offered
Table 13. Predictive and Presymptomatic Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Predictive and Presymptomatic Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Predictive and Presymptomatic Testing Market Size Market Share by Regions (2017-2022)
Table 18. Americas Predictive and Presymptomatic Testing Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Predictive and Presymptomatic Testing Market Size Market Share by Country (2017-2022)
Table 20. Americas Predictive and Presymptomatic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
Table 22. Americas Predictive and Presymptomatic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
Table 24. APAC Predictive and Presymptomatic Testing Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Predictive and Presymptomatic Testing Market Size Market Share by Region (2017-2022)
Table 26. APAC Predictive and Presymptomatic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
Table 28. APAC Predictive and Presymptomatic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
Table 30. Europe Predictive and Presymptomatic Testing Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Predictive and Presymptomatic Testing Market Size Market Share by Country (2017-2022)
Table 32. Europe Predictive and Presymptomatic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
Table 34. Europe Predictive and Presymptomatic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Predictive and Presymptomatic Testing Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Predictive and Presymptomatic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Predictive and Presymptomatic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Predictive and Presymptomatic Testing
Table 43. Key Market Challenges & Risks of Predictive and Presymptomatic Testing
Table 44. Key Industry Trends of Predictive and Presymptomatic Testing
Table 45. Global Predictive and Presymptomatic Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Predictive and Presymptomatic Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Predictive and Presymptomatic Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Predictive and Presymptomatic Testing Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Predictive and Presymptomatic Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Predictive and Presymptomatic Testing Market Size Market Share Forecast by Application (2023-2028)
Table 51. 23andMe, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 52. 23andMe, Inc. Predictive and Presymptomatic Testing Product Offered
Table 53. 23andMe, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. 23andMe, Inc. Main Business
Table 55. 23andMe, Inc. Latest Developments
Table 56. Abbott Molecular, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 57. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product Offered
Table 58. Abbott Molecular, Inc. Main Business
Table 59. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Abbott Molecular, Inc. Latest Developments
Table 61. BioAxis DNA Research Centre Private Limited Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 62. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product Offered
Table 63. BioAxis DNA Research Centre Private Limited Main Business
Table 64. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. BioAxis DNA Research Centre Private Limited Latest Developments
Table 66. Color Genomics, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 67. Color Genomics, Inc. Predictive and Presymptomatic Testing Product Offered
Table 68. Color Genomics, Inc. Main Business
Table 69. Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Color Genomics, Inc. Latest Developments
Table 71. Direct Laboratory Services LLC (DirectLabs) Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 72. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product Offered
Table 73. Direct Laboratory Services LLC (DirectLabs) Main Business
Table 74. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Direct Laboratory Services LLC (DirectLabs) Latest Developments
Table 76. Gene by Gene Ltd. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 77. Gene by Gene Ltd. Predictive and Presymptomatic Testing Product Offered
Table 78. Gene by Gene Ltd. Main Business
Table 79. Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Gene by Gene Ltd. Latest Developments
Table 81. Genomic Diagnostics Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 82. Genomic Diagnostics Predictive and Presymptomatic Testing Product Offered
Table 83. Genomic Diagnostics Main Business
Table 84. Genomic Diagnostics Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Genomic Diagnostics Latest Developments
Table 86. Mapmygenome Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 87. Mapmygenome Predictive and Presymptomatic Testing Product Offered
Table 88. Mapmygenome Main Business
Table 89. Mapmygenome Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Mapmygenome Latest Developments
Table 91. Myriad Genetics, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 92. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product Offered
Table 93. Myriad Genetics, Inc. Main Business
Table 94. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Myriad Genetics, Inc. Latest Developments
Table 96. Pathway Genomics Corporation Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 97. Pathway Genomics Corporation Predictive and Presymptomatic Testing Product Offered
Table 98. Pathway Genomics Corporation Main Business
Table 99. Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Pathway Genomics Corporation Latest Developments
Table 101. Positive Bioscience, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 102. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product Offered
Table 103. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Positive Bioscience, Inc. Main Business
Table 105. Positive Bioscience, Inc. Latest Developments
Table 106. Quest Diagnostics, Inc. Details, Company Type, Predictive and Presymptomatic Testing Area Served and Its Competitors
Table 107. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product Offered
Table 108. Quest Diagnostics, Inc. Main Business
Table 109. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Quest Diagnostics, Inc. Latest Developments
LIST OF FIGURES
LIST OF FIGURES
Figure 1. Predictive and Presymptomatic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Predictive and Presymptomatic Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Predictive and Presymptomatic Testing Market Size Market Share by Type in 2021
Figure 7. Predictive and Presymptomatic Testing in Breast and Ovarian Cancer
Figure 8. Global Predictive and Presymptomatic Testing Market: Breast and Ovarian Cancer (2017-2022) & ($ Millions)
Figure 9. Predictive and Presymptomatic Testing in Colorectal Cancer
Figure 10. Global Predictive and Presymptomatic Testing Market: Colorectal Cancer (2017-2022) & ($ Millions)
Figure 11. Predictive and Presymptomatic Testing in Alzheimer's Disease
Figure 12. Global Predictive and Presymptomatic Testing Market: Alzheimer's Disease (2017-2022) & ($ Millions)
Figure 13. Predictive and Presymptomatic Testing in Multiple Endocrine Neoplasia Type 2
Figure 14. Global Predictive and Presymptomatic Testing Market: Multiple Endocrine Neoplasia Type 2 (2017-2022) & ($ Millions)
Figure 15. Predictive and Presymptomatic Testing in Haemochromatosis
Figure 16. Global Predictive and Presymptomatic Testing Market: Haemochromatosis (2017-2022) & ($ Millions)
Figure 17. Global Predictive and Presymptomatic Testing Market Size Market Share by Application in 2021
Figure 18. Global Predictive and Presymptomatic Testing Revenue Market Share by Player in 2021
Figure 19. Global Predictive and Presymptomatic Testing Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Predictive and Presymptomatic Testing Market Size 2017-2022 ($ Millions)
Figure 21. APAC Predictive and Presymptomatic Testing Market Size 2017-2022 ($ Millions)
Figure 22. Europe Predictive and Presymptomatic Testing Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Predictive and Presymptomatic Testing Market Size 2017-2022 ($ Millions)
Figure 24. Americas Predictive and Presymptomatic Testing Value Market Share by Country in 2021
Figure 25. Americas Predictive and Presymptomatic Testing Consumption Market Share by Type in 2021
Figure 26. Americas Predictive and Presymptomatic Testing Market Size Market Share by Application in 2021
Figure 27. United States Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Predictive and Presymptomatic Testing Market Size Market Share by Region in 2021
Figure 32. APAC Predictive and Presymptomatic Testing Market Size Market Share by Application in 2021
Figure 33. China Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Predictive and Presymptomatic Testing Market Size Market Share by Country in 2021
Figure 40. Europe Predictive and Presymptomatic Testing Market Size Market Share by Type in 2021
Figure 41. Europe Predictive and Presymptomatic Testing Market Size Market Share by Application in 2021
Figure 42. Germany Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Application in 2021
Figure 50. Egypt Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 56. APAC Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 57. Europe Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 59. United States Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 60. Canada Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 63. China Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 64. Japan Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 65. Korea Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 67. India Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 68. Australia Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 69. Germany Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 70. France Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 71. UK Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 72. Italy Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 73. Russia Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 74. Spain Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 77. Israel Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
LIST OF FIGURES
Figure 1. Predictive and Presymptomatic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Predictive and Presymptomatic Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Predictive and Presymptomatic Testing Market Size Market Share by Type in 2021
Figure 7. Predictive and Presymptomatic Testing in Breast and Ovarian Cancer
Figure 8. Global Predictive and Presymptomatic Testing Market: Breast and Ovarian Cancer (2017-2022) & ($ Millions)
Figure 9. Predictive and Presymptomatic Testing in Colorectal Cancer
Figure 10. Global Predictive and Presymptomatic Testing Market: Colorectal Cancer (2017-2022) & ($ Millions)
Figure 11. Predictive and Presymptomatic Testing in Alzheimer's Disease
Figure 12. Global Predictive and Presymptomatic Testing Market: Alzheimer's Disease (2017-2022) & ($ Millions)
Figure 13. Predictive and Presymptomatic Testing in Multiple Endocrine Neoplasia Type 2
Figure 14. Global Predictive and Presymptomatic Testing Market: Multiple Endocrine Neoplasia Type 2 (2017-2022) & ($ Millions)
Figure 15. Predictive and Presymptomatic Testing in Haemochromatosis
Figure 16. Global Predictive and Presymptomatic Testing Market: Haemochromatosis (2017-2022) & ($ Millions)
Figure 17. Global Predictive and Presymptomatic Testing Market Size Market Share by Application in 2021
Figure 18. Global Predictive and Presymptomatic Testing Revenue Market Share by Player in 2021
Figure 19. Global Predictive and Presymptomatic Testing Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Predictive and Presymptomatic Testing Market Size 2017-2022 ($ Millions)
Figure 21. APAC Predictive and Presymptomatic Testing Market Size 2017-2022 ($ Millions)
Figure 22. Europe Predictive and Presymptomatic Testing Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Predictive and Presymptomatic Testing Market Size 2017-2022 ($ Millions)
Figure 24. Americas Predictive and Presymptomatic Testing Value Market Share by Country in 2021
Figure 25. Americas Predictive and Presymptomatic Testing Consumption Market Share by Type in 2021
Figure 26. Americas Predictive and Presymptomatic Testing Market Size Market Share by Application in 2021
Figure 27. United States Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Predictive and Presymptomatic Testing Market Size Market Share by Region in 2021
Figure 32. APAC Predictive and Presymptomatic Testing Market Size Market Share by Application in 2021
Figure 33. China Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Predictive and Presymptomatic Testing Market Size Market Share by Country in 2021
Figure 40. Europe Predictive and Presymptomatic Testing Market Size Market Share by Type in 2021
Figure 41. Europe Predictive and Presymptomatic Testing Market Size Market Share by Application in 2021
Figure 42. Germany Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Predictive and Presymptomatic Testing Market Size Market Share by Application in 2021
Figure 50. Egypt Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Predictive and Presymptomatic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 56. APAC Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 57. Europe Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 59. United States Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 60. Canada Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 63. China Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 64. Japan Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 65. Korea Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 67. India Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 68. Australia Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 69. Germany Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 70. France Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 71. UK Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 72. Italy Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 73. Russia Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 74. Spain Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 77. Israel Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Predictive and Presymptomatic Testing Market Size 2023-2028 ($ Millions)
